Active Non Infectious Intermediate Posterior And Panuveitis Trials
Israel, Ramat Gan
Austria, Graz Steiermark
This study aims at evaluating real life effectiveness of originator adalimumab (Humira®) participants with active non-infectious intermediate, posterior and panuveitis (NIIPPU) despite high-dose corticosteroid therapy; including effect on ocular inflammation, health-related qual...
Male & Female
18 - 99
Connect with PatientWingLike Us Follow Us
Get all the latest studies in your inbox! Sign up for the PatientWing newsletter today!Sign me up
Looking to enroll patients? List your studies here
Streamline your enrollment process and get better qualified patients through PatientWing.Get started
Healthy and want to help?
By participating in clinical trials, you help advance the medical science and may be compensated for your time. Hooray!!See what's available